Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Rakesh Sharma, PhD

216.444.8182

Rakesh Sharma, Ph.D.

Appointed: 1997

No Patient Satisfaction Reviews
Rakesh Sharma, PhD
Department: Urology
Project Staff
Location: Cleveland Clinic Main Campus
Mail Code X11
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.8182
WorkFax:216.445.6049
Rakesh Sharma, PhD
Department: Obstetrics and Gynecology
Project Staff
Location: Cleveland Clinic Main Campus
Mail Code X11
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.8182
WorkFax:216.445.6049
Surgeon:
No
Type of Doctor:
Adults Only

Biographical Sketch

Rakesh Sharma, PhD, received his Master's of Science degree in 1983 and his PhD in 1992 from Panjab University, Chandigarh, India. He completed his postdoctoral training at Cleveland Clinic. He is a recipient of an American Foundation for Urologic Disease (AFUD) Fellowship from 1999-2001. Dr. Sharma was appointed as Project Staff in 1999 in the Glickman Urological and Kidney Institute, Obstetrics and Gynecology and the Women’s Institute at Cleveland Clinic. He has been Coordinator of the Reproductive Research Center since 2006.

Dr. Sharma has published over 130 scientific papers and review articles in peer-reviewed scientific journals, authored seven book chapters and has presented 300 abstracts at both national and international scientific meetings. He is a member of several professional societies, including the American Society of Reproductive Medicine, American Society of Andrology, Society for Medicine and Reproductive Urology and the Society for the Study of Male Reproduction.

Dr. Sharma is an ad hoc reviewer for the Journal of Andrology, International Journal of Andrology, Urology, Reproductive Biomedicine Online, Biology of Reproduction, Human Reproduction, Fertility & Sterility and Asian Journal of Andrology.
 
Dr. Sharma is an investigator on 50 research grants. His current research interests include the role of free radicals in male and female infertility, oxidative stress and DNA integrity, apoptosis and semen quality, sperm cryopreservation, oxidative stress and embryo quality and endometriosis associated infertility.

Professional Highlights

American Foundation for Urological Diseases (AFUD) Scholar, 1999-2001

Education & Fellowships

Fellowship - Cleveland Clinic
Urology
Cleveland, OH USA
1997
Doctorate - Panjab University
India
1992
Undergraduate - Panjab University
Biophysics
India
1981

Specialty Interests

Cryopreservation, DNA damage, endometriosis associated infertility, Male and female infertility, ovarian transplantation and cryopreservation, oxidative stress

Innovations & Patents

Innovator Award, Cleveland Clinic Innovations, 2007

  • Supplementation of L-carnitine in the culture media causes a significant decrease in DNA damage and improves embryo quality: a novel finding
  • Characterization of intracellular reactive oxygen species from human spermatozoa: a novel method for male infertility diagnosis  

Memberships

  • American Society of Reproductive Medicine
  • American Society of Andrology
  • Society of Male Reproduction and Urology

Treatment & Services

  • Cryopreservation
  • Ovarian Transplantation
  • Urology

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/7/2015, Dr. Sharma has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English